No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹20.58Prev. Close
₹20.5Turnover(Lac.)
₹1.28Day's High
₹20.58Day's Low
₹20.5852 Week's High
₹24.3752 Week's Low
₹15.75Book Value
₹12.34Face Value
₹10Mkt Cap (₹ Cr.)
6.17P/E
0EPS
0Divi. Yield
04 Sep 2025
12:00 AM
AGM
Announcement Date: 04 Sep, 2025
25 Mar 2026
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 0.36 | 2.06 | 3.31 | 4.22 |
Net Worth | 3.36 | 5.06 | 6.31 | 7.22 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 34.97 | 49.61 | 55.78 | 60.54 |
yoy growth (%) | -29.5 | -11.05 | -7.86 | 29.14 |
Raw materials | -30.02 | -42.1 | -48.84 | -52.19 |
As % of sales | 85.84 | 84.85 | 87.56 | 86.19 |
Employee costs | -2.36 | -3.08 | -2.98 | -1.98 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.35 | 0.81 | 1.96 | 1.75 |
Depreciation | -0.03 | -0.03 | -0.03 | -0.03 |
Tax paid | -0.19 | -0.22 | -0.67 | -0.36 |
Working capital | -0.47 | 1.27 | 0.39 | 3.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -29.5 | -11.05 | -7.86 | 29.14 |
Op profit growth | -181.67 | -62.6 | 59.04 | -13.56 |
EBIT growth | -137.15 | -56.93 | 10.78 | 30.06 |
Net profit growth | -193.12 | -53.86 | -7.99 | 46.66 |
| Particulars (Rupees in Crores.) | Mar-2023 |
|---|---|
Gross Sales | 0.48 |
Excise Duty | 0 |
Net Sales | 0.48 |
Other Operating Income | 0 |
Other Income | 0.24 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,863.15 | 100.3 | 4,37,734.67 | 705.44 | 0.88 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,922.05 | 70.09 | 1,80,311.57 | 598 | 0.44 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,409.1 | 65.09 | 1,45,369.09 | 577 | 0.14 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,438.65 | 28.97 | 1,07,204.87 | 384.64 | 0.98 | 3,840.92 | 423.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,302.8 | 32.79 | 1,05,592.45 | -219.4 | 0.63 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Director
B R Gupta
Non Executive Director
Brij Bala Gupta.
Independent Non Exe. Director
Mayank Jain
Independent Non Exe. Director
Pooja Jha
Company Sec. & Compli. Officer
Priyanka Sharma
C-64 Lajpat Nagar-1 1st Floor,
New Delhi - 110024
Tel: -
Website: http://www.brawnbiotech.com
Email: solution@brawnbiotech.com
B-106 Sector-2,
Okhla Industrial Are, Phase II,
Noida-201301
Tel: 91-0120-4015880
Website: www.rcmcdelhi.com
Email: shares@rcmcdelhi.com
Summary
Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985. Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to ...
Read More
Reports by Brawn Biotech Ltd
What is the Brawn Biotech Ltd share price today?
What is the Market Cap of Brawn Biotech Ltd?
What is the PE and PB ratio of Brawn Biotech Ltd?
What is the 52 Week High and Low of Brawn Biotech Ltd?
What is the CAGR of Brawn Biotech Ltd?
What is the shareholding pattern of Brawn Biotech Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
